Scientific sessions, PRBB CRG Conferences
Strategy and New Projects, TiGenix. Madrid, Spain
Miguel Mulet, Director of Strategy and New Projects of TiGenix. His primary role at TiGenix is focused on aligning the functions that drive the cell therapy pipeline in Crohn’s Disease and Acute Myocardial Infarct. In addition, and besides business development activities to broaden the current pipeline, he is in charge of advancing the market readiness of the current platforms through implementation of new technologies and process improvement initiatives.
He has been invited by Pablo Cironi (TBDO - CRG).